HighTower Advisors
MDLN

HighTower Advisors’s Medline Inc MDLN Stock Holding History

HighTower Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$667K Buy
16,920
+1,505
+10% +$60.6K ﹤0.01% 2525
2026
Q1 		$686K Buy
15,415
+2,663
+21% +$118K ﹤0.01% 2461
2025
Q4 		$536K Buy
+12,752
New +$539K ﹤0.01% 2559

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HighTower Advisors's MDLN Position: Q2 2026 in Review

HighTower Advisors increased its Medline Inc (MDLN) stake by 9.8% in Q2 2026, buying an estimated $60.6K and bringing the position to 16,920 shares worth $667K. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

HighTower Advisors first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $686K in Q1 2026. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • HighTower Advisors held 16,920 shares of Medline Inc worth $667K as of Q2 2026.
  • HighTower Advisors bought 1,505 Medline Inc shares in Q2 2026, an estimated $60.6K.
  • Medline Inc made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2525 holding.
  • HighTower Advisors first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • HighTower Advisors's Medline Inc position peaked at $686K in Q1 2026.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.